PRESS RELEASE: CATALYZE UNVEILS LAUNCH OF NEW BRAND IDENTITY

New Brand Identity Representative of Company Ambitions

23 July 2019 Amsterdam, Netherlands

As of July 23rd  2019, Catalyze is presenting a new strategic global brand identity, representing their position as market leader in obtaining funding for biomedical and healthcare innovations. 

 

This new chapter in the company journey is reflective of their ever-evolving, rapidly growing business. The new Catalyze logo and visual identity encapsulates the vision that founders Theodoor Rutgers, Jalal Es-Sbai, and Peter Schoevers have in representing the company’s pillar values of innovation, growth, and sustainability. 

 

According to Theodoor Rutgers, “As a consultancy firm, we aim to corner the market in life sciences. Through our specialized services we aim to positively impact scientific progress towards better treatments, diagnostics and other life science technologies, ultimately improving the lives of millions of patients around the world.” 

 

Over the last 10 years, Catalyze has grown to employ over 75 international expert professionals with offices in Amsterdam, Utrecht, Copenhagen, and Basel. The launch of the new Catalyze brand identity also coincides the same summer as their breakthrough new collaboration in the United States with BioHealth Innovation Inc., where Catalyze is pivoting next towards expanding its global presence.  

 

“We aim to continue developing into a full-service, global consultancy firm. As a company, we want to make impact and accelerate pharma-tech innovations,” says Theodoor Rutgers. “This is just the beginning.”  

 

 

 

ABOUT CATALYZE

Catalyze is a market leader in obtaining funding for biomedical and healthcare innovations. Catalyze helps leading researchers, SME’s and companies to secure financing for ambitious R&D projects, from early stage pre-clinical research up to clinical stage development and beyond. Catalyze provides funding consultancy and related services to selected, meaningful and innovative projects. The company aims to make sure that these projects are securely funded and that the research and development strategy is geared to a maximum chance of success. Catalyze supports a variety of Life Sciences developments including, but not limited to, healthcare solutions, medical devices, diagnostics, pharmaceuticals, Agri-Food and Bioeconomy. The company has a strong passion for the latest technological innovations and its top consultants work with the best clients and projects in Europe and beyond. 

### 

If you would like more information about this topic, please contact commercial manager Kirsten van Benthem at kirsten.vanbenthem@catalyze-group.com    

Newsletter

A must-have if you’re interested in getting your business to the next level